Sector Chart MannKind Corporation

Stocks

MNKD

US56400P7069

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 11:49:49 2026-10-16 EDT			5-day change	1st Jan Change
3.105 ^USD	-2.66%		-5.62%	-45.24%

10-10	Mannkind Corporation Presents New Clinical Data Related to Furoscix Readyflow At Heart Failure Society of America Annual Scientific Meeting	CI
09-09	MannKind Corporation and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
MANNKIND CORPORATION	1.03B			-	-	-
WUXI APPTEC CO., LTD.	68.98B
ARGENX SE	53.15B
LONZA GROUP AG	50.83B
IQVIA HOLDINGS INC.	44.61B
REVOLUTION MEDICINES, INC.	40.57B	-	-	-	-	-